IQVIA™ Real-World Insights Bibliography

Predicting Hospitalization Due to COPD Exacerbations in Swedish Primary Care Patients Using Machine Learning ? Based on the ARCTIC Study
Author(s): Björn Ställberg 1, Karin Lisspers 1, Kjell Larsson 2, Christer Janson 3, Mario Müller 4, Mateusz Łuczko 5, Bine Kjøller Bjerregaard 6, Gerald Bacher 7, Björn Holzhauer 7, Pankaj Goyal 7, Gunnar Johansson 1
Affiliations(s): 1Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden. 2Integrative Toxicology, Karolinska Institutet, Stockholm, Sweden. 3Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden. 4Department of Data Science and Advanced Analytics, IQVIA, Frankfurt Am Main, Germany. 5Department of Data Science and Advanced Analytics, IQVIA, Warsaw, Poland. 6Department of Real World Evidence Solutions, IQVIA, Copenhagen, Denmark. 7Department of Clinical Development and Analytics, Novartis Pharma AG, Basel, Switzerland.
Publication(s):  Journal: Int J Chron Obstruct Pulmon Dis. 2021 Mar 16;16:677-688. doi: 10.2147/COPD.S293099. eCollection 2021. Conference: IPCRG, Dublin, Ireland, Weekly series of Clinical Practice Webinars - Various Saturdays from 16th May to 27th June 2020
PMID: 33758504 PMCID: PMC7981164 DOI: 10.2147/COPD.S293099
Document Type(s): Article,
Countries: Sweden,
Click here for the abstract
C:
Y:
Respiratory disease,
2021
  L:
A:
English
Epidemiological study, Population Based Study,
  Add to report
 
 
Developing a short-term prediction model for asthma exacerbations from Swedish primary care patients? data using machine learning - based on the ARCTIC study Respiratory Medicine
Author(s): Karin Lisspers a,*, Bj¨orn St¨allberg a, Kjell Larsson b, Christer Janson c, Mario Müller d, Mateusz Łuczko e, Bine Kjøller Bjerregaard f, Gerald Bacher g, Bj¨orn Holzhauer g, Pankaj Goyal g, Gunnar Johansson a
Affiliations(s): a Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden b Integrative Toxicology, Karolinska Institutet, Stockholm, Sweden c Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden d IQVIA, Frankfurt am Main, Germany e IQVIA, Warsaw, Poland f IQVIA, Copenhagen, Denmark g Novartis Pharma AG, Basel, Switzerland
Publication(s): 
Document Type(s): 
Countries: Sweden,
Click here for the abstract
C:
Y:
Respiratory disease,
2021
  L:
A:
English
Clinical setting: Primary care, clinical setting: Secondary care, Predictive analytics,
  Add to report
 
 
Interferon beta Exposure in the 2nd and 3rd Trimester of Pregnancy - a Register-based Drug Utilisation Study in Finland and Sweden
Author(s): Meritxell Sabidó1, Kiliana Suzart-Woischnik2, Nydjie Grimes3, Lisa M Prach4, Liwei Zhao5, Katja M Hakkarainen5
Affiliations(s): 1Merck Healthcare KGaA; 2Bayer AG; 3Biogen Netherlands B.V.; 4Novartis Pharma AG; 5Global Database Studies, IQVIA
Publication(s):  ECTRIMS 2021, Digital, 13-15 October 2021
Document Type(s): Abstract,
Countries: Finland, Sweden,
Click here for the abstract
C:
Y:
Drug Utlization Study, Neurological disorders,
2021
  L:
A:
English
Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Population Based Study, Retrospective database analysis,
  Add to report
 
 
Interferon beta Exposure in the 2nd and 3rd Trimester of Pregnancy - a Register-based Drug Utilisation Study in Finland and Sweden
Author(s): Meritxell Sabidó1, Kiliana Suzart-Woischnik2, Nydjie Grimes3, Lisa M Prach4, Liwei Zhao5, Katja M Hakkarainen5
Affiliations(s): 1Merck Healthcare KGaA; 2Bayer AG; 3Biogen Netherlands B.V.; 4Novartis Pharma AG; 5Global Database Studies, IQVIA
Publication(s):  ECTRIMS 2021, Digital, 13-15 October 2021
Document Type(s): Poster,
Countries: Finland, Sweden,
Click here for the abstract
C:
Y:
Drug Utlization Study, Neurological disorders,
2021
  L:
A:
English
Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Population Based Study, Retrospective database analysis,
  Add to report
 
 
Predicting hospitalization of Swedish patients due to COPD exacerbation with machine learning
Author(s): Karin Lisspers, Uppsala University Christer Janson, Uppsala University Gunnar Johansson, Uppsala University Kjell Larsson, Karolinska Institutet Björn Ställberg, Uppsala University Mario Mueller, IQVIA Mateusz Luczko, IQVIA Bine Kjoeller Bjerregaard, IQVIA Stuart Fell, IQVIA Gerald Bacher, Novartis Bjorn Holzhauer, Novartis Pankaj Goyal, Novartis Pharma AG
Affiliations(s): Uppsala University, IQVIA Denmark, IQVIA Germany, IQVIA Poland
Publication(s):  IPCRG, International Primary Care Respiratory Group Conference 2020
Document Type(s): Oral presentation,
Countries: Sweden,
Click here for the abstract
C:
Y:
Respiratory disease,
2020
  L:
A:
English
  Add to report
 
 
Infections in patients with multiple sclerosis: A national cohort study in Sweden
Author(s): Anna Castelo-Branco, Flaminia Chiesa, Simona Conte, Camilla Bengtsson , Sally Lee, Neil Minton, Steve Niemcryk, Anders Lindholm, Mats Rosenlund, Fredrik Piehl, Scott Montgomery
Affiliations(s): 1.Real-world Insights, IQVIA Nordics, Solna, Sweden 2. Celgene Corporation, Summit, NJ, USA
Publication(s):  Mult Scler Relat Disord. 2020;45:102420. [published online ahead of print, 2020 Jul 23].
Document Type(s): Abstract,
Countries: Sweden,
Click here for the abstract
C:
Y:
Infectious disease, Neurological disorders, Patient Registries & Real-World Study Methods,
2020
  L:
A:
English
Epidemiological study,
  Add to report
 
 
Non-infectious comorbidity in patients with multiple sclerosis: A national cohort study in Sweden
Author(s): Anna Castelo-Branco, Flaminia Chiesa, Camilla E Bengtsson , Sally Lee, Neil N Minton, Steve Niemcryk, Anders Lindholm, Mats Rosenlund, Fredrik Piehl, Scott Montgomery
Affiliations(s): 1.Real-world Insights, IQVIA Nordics, Solna, Sweden 2. Celgene Corporation, Summit, NJ, USA
Publication(s):  Mult Scler J Exp Transl Clin. 2020 Jul-Sep; 6(3): 2055217320947761. Published online 2020 Aug 14
Document Type(s): Article,
Countries: Sweden,
Click here for the abstract
C:
Y:
Cardiovascular disease, Neurological disorders, Patient Registries & Real-World Study Methods,
2020
  L:
A:
English
Epidemiological study, Observational study, Population Based Study, Retrospective cohort analysis,
  Add to report
 
 
Hospitalizations and outpatient vists (H&OV) in moderate and severe acute graft versus host disease (aGVHD) patients in Finland and Sweden
Author(s): Itälä-Remes M1, Viayna E2, Nicklasson M3, Keränen M4, Thunström D5, Pfeiffer M5, Roset M2, Lara N2, Sabatelli L5
Affiliations(s): 1 Turku University Hospital, Finland 2 IQVIA, Real World Solutions, Barcelona, Spain 3 Sahlgrenska, University Hospital, Gothenburg, Sweden 4 Helsinki University Hospital, Finland 5 Incyte Biosciences International, Morges, Switzerland
Publication(s):  ISPOR 2020 Annual European Congress. 14-18 November 2020. Milan, Italy
Document Type(s): Poster,
Countries: Finland, Sweden,
Click here for the abstract
C:
Y:
Hematology, Transplant,
2020
  L:
A:
English
Population Based Study, Retrospective cohort analysis,
  Add to report
 
 
Osteoporosis and fracture risk associated with ICS use among Swedish COPD patients: the ARCTIC study
Author(s): Christer Janson, Karin Lisspers, Björn Ställberg, Gunnar Johansson, Florian S. Gutzwiller, Karen Mezzi, Linda Mindeholm, Bine Kjoeller Bjerregaard, Leif Jorgensen, Kjell Larsson
Affiliations(s): 1Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden; 2Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden; 3Novartis Pharma AG, Basel, Switzerland; 4Novartis Institutes for Biomedical Research (NIBR), Cambridge, USA and Basel, Switzerland; 5IQVIA Solutions, Copenhagen, Denmark; 6Intergrative Toxicology, National Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden
Publication(s):  Eur Respir J 2020; in press (https://doi.org/10.1183/13993003.00515-2020).
Document Type(s): Article,
Countries: Sweden,
Click here for the abstract
C:
Y:
Respiratory disease,
2020
  L:
A:
English
Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Retrospective database analysis,
  Add to report
 
 
Inhaled corticosteroids and the risk of type 2 diabetes among Swedish COPD patients
Author(s): Björn Ställberg 1✉, Christer Janson2, Karin Lisspers1, Gunnar Johansson1, Florian S. Gutzwiller 3, Karen Mezzi3, Bine Kjoeller Bjerregaard 4, Anne Mette Tranberg Kejs4, Leif Jorgensen4 and Kjell Larsson5
Affiliations(s): 1Department of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden. 2Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden. 3Novartis Pharma AG, Basel, Switzerland. 4IQVIA Solutions, Copenhagen, Denmark. 5Integrative Toxicology, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. ?email: b.stallberg@telia.com
Publication(s):  npj Primary Care Respiratory Medicine (2020) 30:47 ; https://doi.org/10.1038/s41533-020-00207-7
Document Type(s): Article,
Countries: Sweden,
C:
Y:
Respiratory disease,
2020
  L:
A:
English
Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Retrospective database analysis,
  Add to report
 
 
 1 of 21 Next Page Last Page